Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

News

  • Home
  •  
  • News



  • Most Read
  • Latest Comments
  • Opening a new frontier in treating Parkinson’s disease
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Opening a new frontier in treating Parkinson’s disease
    • News

    Smart pain assessment app now used by more than half of Australia’s residential aged care providers
    Public
  • Opening a new frontier in treating Parkinson’s disease
    • News

    Fledgling fintech hopes millennials put their Douugh into micro-investing ‘super’ app
    Public
  • Opening a new frontier in treating Parkinson’s disease
    • News

    🎵 The knee bone’s connected to the… collagen rope device (?!)
    Public
  • Opening a new frontier in treating Parkinson’s disease
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial
    • Review
    • September 1, 2022

Latest Articles

  • Syntara prepares for new clinical trials led by Professor Fiona Wood to restore elasticity into burn scars
    Syntara prepares for new clinical trials led by Professor Fiona Wood to restore elasticity into burn scars
    • News

  • First patients dosed in Phase 2 clinical trials to tackle Parkinson’s disease
    First patients dosed in Phase 2 clinical trials to tackle Parkinson’s disease
    • News

  • Pharmaxis accelerates clinical drug developments with additional resources via sale of mannitol business to Arna Pharma
    Pharmaxis accelerates clinical drug developments with additional resources via sale of mannitol business to Arna Pharma
    • News

  • Garvan Institute preclinical study identifies potential of Pharmaxis drug to boost pancreatic cancer survival rate by 35%
    Garvan Institute preclinical study identifies potential of Pharmaxis drug to boost pancreatic cancer survival rate by 35%
    • News

  • Encouraged by interim data, FDA approves Pharmaxis to expand its myelofibrosis treatment trials
    Encouraged by interim data, FDA approves Pharmaxis to expand its myelofibrosis treatment trials
    • News

  • Class sweeps tech awards as Australia’s top Wealth Management & SMSF platform
    • News

    Class sweeps tech awards as Australia’s top Wealth Management & SMSF platform

    At a time when digitisation of financial services is being accelerated to improve regulatory compliance, fintech company Class Limited (ASX: CL1) has dominated the Wealth Management & SMSF category at the 2021 the Australian Digital Technology Awards. The awards recognise digital technology companies that provide outstanding outcomes within the financial services industry across Mortgages, Law,

    Read More
    Public
  • Mosquitoes suck. Island Pharmaceuticals does not.
    • News

    Mosquitoes suck. Island Pharmaceuticals does not.

    Fun fact: The word mosquito actually translates to “little fly” in Spanish. Although you’re more likely to hear them called a whole host of profanities in many households. Little f***ers. If the blood sucking pests weren’t annoying enough, they carry diseases like dengue fever. An estimated 390 million people are infected with dengue each year.

    Read More
    Public
  • Nutritional Growth Solutions launches new snack bar to grow kids taller
    • News

    Nutritional Growth Solutions launches new snack bar to grow kids taller

    Ever noticed how the nutritional supplements that line the aisles of supermarkets and pharmacies are either for adults or children under the age of three? What about the kids in the middle? Key development continues well past the age of three and optimal nutrition plays a huge role in reaching developmental milestones. Addressing this long

    Read More
    Public
  • 100% positive customer reviews drive Harris Technology sales
    • News

    100% positive customer reviews drive Harris Technology sales

    100% customer satisfaction is something all retailers dream of but Harris Technology (ASX: HT8) is one of the very few that have achieved it on the world’s largest marketplace.  Having long been a leading retailer of IT products and consumer electronics, Harris Technology emerged as the number one ranked technology retailer on Amazon’s Australian marketplace

    Read More
    Public
  • Medtech device sales a key step forward for LBT Innovations
    • News

    Medtech device sales a key step forward for LBT Innovations

    LBT Innovations (ASX: LBT) has this morning announced the sale of two of their AI pathology instruments. The Adelaide based med tech company is a leader in medical technology automation through the use of artificial intelligence.  Their flagship product is the APAS® Independence. The Automated Plate Assessment System (APAS®) technology integrates AI to automate culture

    Read More
    Public
  • Fortescue takes K2fly’s ‘social licence’ software global with 3-year extension
    • News

    Fortescue takes K2fly’s ‘social licence’ software global with 3-year extension

    In a big show of confidence towards resources tech company K2fly (ASX: K2F), global mining company Fortescue Metals Group (ASX: FMG) has extended their engagement by 3-years which includes plans to streamline  operations onto K2fly software. The contract extension is valued at $1.45 million over the three years and will take the partnership into its

    Read More
    Public
  • BWX to acquire beauty and wellness online retailer Flora & Fauna
    • News

    BWX to acquire beauty and wellness online retailer Flora & Fauna

    The clean and natural beauty movement is well and truly mainstream. The rise of conscious consumerism has seen the natural beauty and wellbeing market grow by over 12% annually.  The proliferation of small brands that gain cult following are eroding the market share of the big players.  BWX (ASX: BWX) is a leading wellness business

    Read More
    Public
  • Main Event remains strong asset for Ardent post pandemic
    • News

    Main Event remains strong asset for Ardent post pandemic

    Having long been the target of acquisition talks, Ardent Leisure (ASX: ALG) will be pleased to have held on to Main Event Entertainment when talks went quiet amid the onset of a pandemic. But having held their stake through disastrous trading conditions, the US-based entertainment centre business is now thriving as Americans are flocking to

    Read More
    Public
  • Healthia expands optometry network with more savvy acquisitions
    • News

    Healthia expands optometry network with more savvy acquisitions

    Fresh from their expansion into optometry services, Healthia (ASX: HLA) has hit the ground running, adding two new clinics to their network of more than 200 healthcare businesses as Australia’s fastest-growing allied health company. The two clinics fall within the newly established Eyes & Ears division of Healthia which was formed following their $43 million

    Read More
    Public
  • Strategic Elements: Homegrown innovation to quell invisible threats
    • News

    Strategic Elements: Homegrown innovation to quell invisible threats

    The threat of chemical, biological, radiological and nuclear (CBRN) attacks on both military and civilian populations is growing.  As if we didn’t already have enough to worry about. Anxiety riddled, chronic overthinkers and savvy investors alike will be glad to know that Strategic Elements (ASX: SOR) are working on solutions for autonomous sensing and search

    Read More
    Public
  • «
  • ‹
  • 242
  • 243
  • 244
  • 245
  • 246
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.